Drug: EPIRUBICIN HYDROCHLORIDE. Injury: Interstitial lung disease Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 116865146 | EPIRUBICIN HYDROCHLORIDE. | Interstitial lung disease | AMGEN | 51.00 YR | F | 43 KG | 20160829 | JP |
| 121433612 | EPIRUBICIN HYDROCHLORIDE. | Interstitial lung disease | AMGEN | 0.00 | F | 46 KG | 20160701 | JP |
| 124274373 | EPIRUBICIN HYDROCHLORIDE. | Interstitial lung disease | AMGEN | 6.00 DEC | F | 54 KG | 20160810 | JP |
| 125256732 | EPIRUBICIN HYDROCHLORIDE. | Interstitial lung disease | AMGEN | 65.00 YR | F | 45 KG | 20160722 | JP |
| 125643251 | EPIRUBICIN HYDROCHLORIDE. | Interstitial lung disease | AMGEN | 70.00 YR | F | 0 | 20160718 | JP |
| 125643391 | EPIRUBICIN HYDROCHLORIDE. | Interstitial lung disease | AMGEN | 54.00 YR | F | 0 | 20160718 | JP |
Total Records: 6 Number of Pages: 1